Cooley

Yiming Liu

Deals
2
Latest
Sep 2026
Most deals in
Biotech

Firm

  • Cooley Law firm · 2026 · 2 deals

Often works with

Deals

US deals dated after 30 September 2026 are still being collected.

Columns
Deals Yiming Liu was named on, most recent first
Sep 2026 trispecific T cell-engager (TCE) asset Chimagen BiosciencesGSKAsset saleLegal adviser to Chimagen Biosciences (seller)Announced750.0Biotech+2GSK acquisition of trispecific T cell-engager (TCE) asset
May 2026 IMPACT Therapeutics ––IPOLegal adviser to the issuerListed–Biotech+2IMPACT Therapeutics IPO

Deals where Yiming Liu is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.